Evidence map›Paper›PMID 29402133›Full record

ArticleExperimental biology and medicine (Maywood, N.J.)2018

Featured Article: Immunomodulatory effect of hemozoin on pneumocyte apoptosis via CARD9 pathway, a possibly retarding pulmonary resolution.

Sitang Maknitikul, Natthanej Luplertlop, Urai Chaisri, Yaowapa Maneerat, Sumate Ampawong

Open access · greenAbstract read
In one paragraph

Article in Experimental biology and medicine (Maywood, N.J.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Hemozoin: a Complex Molecule with Complex Activities.Current clinical microbiology reports · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Case Report: The First Direct Evidence ofThe American journal of tropical medicine and hygiene · 2020
    Article
  9. Heme on Pulmonary Malaria: Friend or Foe?Frontiers in immunology · 2020
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sitang Maknitikul1 Department of Tropical Pathology, 115374 Faculty of Tropical Medicine, Mahidol University , Ratchathewi, Bangkok 10400, Thailand.
Natthanej Luplertlop2 Department of Microbiology and Immunology, 115374 Faculty of Tropical Medicine, Mahidol University , Ratchathewi, Bangkok 10400, Thailand.
Urai Chaisri1 Department of Tropical Pathology, 115374 Faculty of Tropical Medicine, Mahidol University , Ratchathewi, Bangkok 10400, Thailand.
Yaowapa Maneerat1 Department of Tropical Pathology, 115374 Faculty of Tropical Medicine, Mahidol University , Ratchathewi, Bangkok 10400, Thailand.
Sumate Ampawong1 Department of Tropical Pathology, 115374 Faculty of Tropical Medicine, Mahidol University , Ratchathewi, Bangkok 10400, Thailand.
Mahidol University · THMahidol Oxford Tropical Medicine Research Unit · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plasmodium falciparum, the most virulent malaria parasite species, causes severe symptoms especially acute lung injury (ALI), of which characterized by alveolar epithelium and endothelium destruction and accelerated to blood-gas-barrier breakdown. Parasitized erythrocytes, endothelial cells, monocytes, and cytokines are all involved in this mechanism, but hemozoin (HZ), the parasitic waste from heme detoxification, also mainly contributes. In addition, it is not clear why type II pneumocyte proliferation, alveolar restorative stage, is rare in malaria-associated ALI. To address this, in vitro culture of A549 cells with Plasmodium HZ or with interleukin (IL)-1β triggered by HZ and monocytes (HZ-IL-1β) was conducted to determine their alveolar apoptotic effect using ethidium bromide/acridine orange staining, annexin-V-FITC/propidium iodide staining, and electron mircroscopic study. Caspase recruitment domain-containing protein 9 ( CARD9), the apoptotic regulator gene, and IL-1β were quantified by reverse-transcriptase PCR. Junctional cellular defects were characterized by immunohistochemical staining of E-cadherin. The results revealed that cellular apoptosis and CARD9 expression levels were extremely high 24 h after induction by HZ-IL-1β when compared to the HZ- and non-treated groups. E-cadherin was markedly down-regulated by HZ-IL-1β and HZ treatments. CARD9 expression was positively correlated with IL-1β expression and the number of apoptotic cells. Interestingly, the localization of HZ in the vesicular surfactant of apoptotic pneumocyte was also identified and submitted to be a cause of alveolar resolution abnormality. Thus, HZ triggers monocytes to produce IL-1β and induces pneumocyte type II apoptosis through CARD9 pathway in association with down-regulated E-cadherin, which probably impairs alveolar resolution in malaria-associated ALI. Impact statement The present work shows the physical and immunomodulatory properties of hemozoin on the induction of pneumocyte apoptosis in relation to IL-1β production through the CARD9 pathway. This occurrence may be a possible pathway for the retardation of lung resolution leading to blood-gas-barrier breakdown. Our findings lead to the understanding of the host-parasite relationship focusing on the dysfunction in ALI induced by HZ, a possible pathway of the recovering lung epithelial retardation in malaria-associated ARDS.

Indexed as

A549 CellsAcute Lung InjuryAlveolar Epithelial CellsAntigens, CDApoptosisCadherinsCARD Signaling Adaptor ProteinsCell Line, TumorHemeproteinsHumansInterleukin-1betaLungMalaria, FalciparumPlasmodium falciparumPulmonary AlveoliTHP-1 CellsAntigens, CDCadherinsCARD9 protein, humanCARD Signaling Adaptor ProteinsCDH1 protein, humanHemeproteinshemozoinIL1B protein, humanInterleukin-1betaAcute lung injuryapoptosisCARD9hemozoininterleukin-1β

Identifiers

PMID29402133
PMCPMC5882027
OpenAlexW2790060817

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.